Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antiphospholipid syndrome.

J C Wautrecht1

  • 1Department of Vascular Diseases, Hôpital Erasme, Brussels. jwautrec@ulb.ac.be

Acta Neurologica Belgica
|January 22, 2003
PubMed
Summary
This summary is machine-generated.

Antiphospholipid syndrome (APS) involves antiphospholipid antibodies causing blood clots. Neurologists must understand APS, as it frequently affects the brain, with anticoagulation being a primary treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening Program of Abdominal Aortic Aneurysm.

Angiology·2019
Same author

Requirements for angiology/vascular medicine.

International angiology : a journal of the International Union of Angiology·2013
Same author

[Thrombocytosis in patients treated with low-molecular-weight heparin: more common than imagined?].

Journal des maladies vasculaires·2010
Same author

[New developments in antithrombotic care].

Revue medicale de Bruxelles·2009
Same author

Spontaneous renal artery dissection in an otherwise healthy male.

Acta chirurgica Belgica·2007
Same author

Accuracy and safety of pretest probability assessment of deep vein thrombosis by physicians in training using the explicit Wells clinical model.

Journal of thrombosis and haemostasis : JTH·2006
Same journal

Synergistic pain relief in cervical radiculopathy: A randomized trial of topical methylcobalamin gel with phonophoresis and Mulligan mobilization.

Acta neurologica Belgica·2026
Same journal

Characterizing cranial tremors in a case of spinocerebellar ataxia type 12: a unique positional tremor.

Acta neurologica Belgica·2026
Same journal

A case of coexistence of spinal intradural capillary hemangioma and craniocervical junction dural arteriovenous fistula.

Acta neurologica Belgica·2026
Same journal

Comment on "Content quality and reliability of youtube exercise videos for parkinson's disease".

Acta neurologica Belgica·2026
Same journal

A novel CHMP2B variant of uncertain significance in a patient with apathy, hyperorality, and mild language impairment.

Acta neurologica Belgica·2026
Same journal

Photon-counting CT-angiography in comparison to digital subtraction angiography and MR-angiography for assessing intra-aneurysmal flow disrupting devices.

Acta neurologica Belgica·2026
See all related articles

Area of Science:

  • Neurology
  • Immunology
  • Hematology

Background:

  • Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies and a hypercoagulable state.
  • Antiphospholipid antibodies include lupus anticoagulants and anticardiolipin antibodies.
  • The exact pathogenesis of APS is still unknown.

Purpose of the Study:

  • To review the biology, diagnosis, and clinical manifestations of APS.
  • To focus on the neurological manifestations of APS.
  • To discuss the treatment of APS, emphasizing anticoagulation.

Main Methods:

  • Literature review and synthesis of existing knowledge on APS.
  • Focus on clinical and laboratory diagnostic criteria.
  • Discussion of treatment strategies, particularly anticoagulation.

Related Experiment Videos

Main Results:

  • APS is linked to hypercoagulability and thrombophilia.
  • Neurological complications are common in APS.
  • Anticoagulation is the cornerstone of APS management.

Conclusions:

  • Understanding APS is crucial for neurologists due to frequent brain involvement.
  • Early diagnosis and appropriate management, including anticoagulation, are vital for patients with APS.
  • Further research into APS pathogenesis may improve treatment outcomes.